2 recruiting, 1 completed, 1 unknown. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Yunfeng Xia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy APP-based management - End Stage Renal Disease (ESRD), Maintenance Hemodialysis | Not applicable | Recruiting | Yunfeng Xia | 392 | 2025-09-22 | 2025-12-18 |
| A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole Dipyridamole 50mg tid - Restless Leg Syndrome Due to Uraemia | Phase 2 / Phase 3 | Recruiting | Yunfeng Xia | 80 | 2025-09-20 | 2026-04-22 |
| The Effect of Active Exercise on Maintenance Haemodialysis Patients exercise - Renal Dialysis | Not applicable | Unknown | Yunfeng Xia | 200 | 2024-01-01 | 2024-08-23 |
| Impact of Regular Low-Frequency Hemoperfusion on Medium- to Long-Term Prognosis in Maintenance Dialysis Patients Regular Low-Frequency Hemoperfusion, Medium- to Long-Term Prognosis | Completed | Yunfeng Xia | 879 | 2015-01-01 | 2026-01-16 |
Inflammation (1) · Kidney Failure, Chronic (1) · Motor Activity (1) · Muscular Atrophy (1) · Restless Legs Syndrome (1) · Uremia (1)
Dipyridamole (1) · Exercise (1)
China (4)